Skip to main content
. 2022 Nov 17;2022(11):CD014963. doi: 10.1002/14651858.CD014963.pub2

Comparison 8. Methylprednisolone versus dexamethasone for hospitalised individuals with a confirmed or suspected diagnosis of symptomatic COVID‐19.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
8.1 All‐cause mortality up to 30 days 1   Risk Ratio (M‐H, Random, 95% CI) Totals not selected